The Pediatric Hematology-Oncology Subspecialty Residency Program at McGill University, based at the Montreal Children's Hospital, is a three year program accredited by the Royal College of Physicians and Surgeons of Canada. Over the course of three years, residents will have 6-9 months of relevant clinical laboratory training. There is a strong commitment and involvement in clinical and fundamental research.
The Montreal Children's Hospital moved to a brand new facility, the Glen Site, in May 2015. A significant advantage of this new site is the proximity of the adult cancer centre, radiotherapy unit, and basic science research building facilitating increased learning opportunities. Our new inpatient HEPA filtered unit has 12 beds including those used for bone marrow transplant. Immediately adjacent to the in-patient unit is the ambulatory care facility with an on-site oncology pharmacy and an 8 bed day treatment unit. Anaesthesia support is provided for oncology procedures under general anesthetic. We have ready access to a full range of diagnostic laboratory testing and state-of-the-art imaging studies, including two MRI’s, one of which is intra-operative. There are strong and cordial interactions with colleagues in other departments with whom we work with frequently such as surgery, pathology, anaesthesia. Patients and families receive support from nurses and allied health services (psychology, nutrition, child life, music and massage therapists, and pastoral care to name a few) and there is a dedicated palliative care service. All patients with malignant disease are considered for enrolment in clinical trials. We are active members in the Children’s Oncology Group and many industry trials available as well. We have a large sickle cell and thalassemia program, a provincially recognized comprehensive hemophilia/hemostasis program, and we treat a broad range of benign hematologic conditions.
Program length: 3 years
Average number of trainees per year: 1
The Pediatric Hematology-Oncology Subspecialty Residency Program follows the training requirements set by the Royal College of Physicians and Surgeons (RCPSC), including the availability of 6-9 months for Clinical Hematology laboratory training.
We have an active hematopoietic stem cell transplant program, and additional training in Hematopoietic Stem Cell Transplant will be undertaken at L’Hôpital Ste. Justine or The Hospital for Sick Children in Toronto, depending on the candidate’s preference.
The ambulatory and in-patient clinical training provides a breadth of experience in both hematology and oncology. A resident is assigned to a specific continuity clinic time throughout their residency to provide a longitudinal experience with their own patients and families coping with malignant or benign disease.
An academic program including protected teaching time, journal club, and grand rounds complements the clinical experience.
The third year of training will place more emphasis on research project and can be tailored to specific interests of the resident and their career plans.
The primary institution is the Montreal Children’s Hospital site of the McGill University Health Center (MUHC). Within the adult sites of the MUHC, there may be rotations in laboratories such as hemostasis/thrombosis, transfusion medicine, and also an adult Hematology clinical experience. At The Hospital for Sick Children or L’Hôpital Ste. Justine, residents can undertake up to three months training in transplantation and may also do other elective rotations. With the necessary approval, elective rotations may be undertaken elsewhere in accredited pediatric hospitals.